Both the Regulatory Science Network Netherlands (RSNN) and the Centre for Future Affordable and Sustainable Therapy development (FAST) aim to advance and innovate the regulatory system, to ultimately improve the development, accessibility, and appropriate use of therapies for patients. From the start of this year, FAST and the RSNN have initiated a collaboration to achieve their shared goals. This new partnership may open further possibilities for future joint activities.

Collaborative effort to innovate the regulatory system
The overlap in interests and compatible network approaches has resulted in the start of a collaborative project between FAST and the RSNN. The goal of this project is to design a tangible and ready-to-implement multi stakeholder model in which promising projects can receive regulatory support. This model shall include balanced regulatory representation supported by all stakeholder groups involved. More clarity and information on the scope of the collaboration is expected in the coming months. The RSNN is looking forward to expanding its partnership with FAST in the future.

About RSNN
The goal of the RSNN is to advance an efficient and effective regulatory system that supports medicines development, marketing authorization, access, and appropriate use of medicines. The RSNN has a leading position within the Netherlands as an organization that brings together extensive regulatory knowledge and experience from key stakeholders in the field. Currently the main activities of the RSNN are to organize meetings and events in which current regulatory topics are discussed and, as a network, responding to publications, and (draft) guidelines.